Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
Charilaos Chourpiliadis(Karolinska Institutet), Fang Fang(Jinshan Hospital of Fudan University), Anikó Lovik(Leiden University), Unnur Valdimarsdóttir(Harvard University), Huan Song(University of Iceland), Niklas Hammar(Karolinska Institutet), Yu Zeng(West China Medical Center of Sichuan University), Dang Wei(Harvard University)
Cited by 139
Related Papers
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
|Journal of the American College of Cardiology|2018|465
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
|Journal of Clinical Oncology|2009|245
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
|Journal of Clinical Oncology|2010|217
Mediterranean diet and depression: a population-based cohort study
|International Journal of Behavioral Nutrition and Physical Activity|2021|138